Jan 27 (Reuters) - Xvivo Perfusion AB XVIVO.ST
* Q4 NET SALES AMOUNTED TO SEK 85.9 MILLION (60.3),
CORRESPONDING
TO AN INCREASE OF 42 PERCENT IN SEK AND 42 PERCENT ALSO IN LOCAL
CURRENCIES
* Q4 NET SALES OF NON-DURABLE GOODS AMOUNTED TO SEK 74.0
MILLION
(54.9), CORRESPONDING TO AN INCREASE OF 35 PERCENT IN SEK AND 34
PERCENT IN LOCAL CURRENCIES
* Q4 OPERATING PROFIT BEFORE DEPRECIATION AND AMORTIZATION
(EBITDA) AMOUNTED TO SEK- 0.1 MILLION (-6.5), CORRESPONDING TO
AN EBITDA MARGIN OF 0 PERCENT (-11)
* Q4 ADJUSTED EBITDA AMOUNTED TO SEK 9.6 MILLION (6.8),
CORRESPONDING TO AN ADJUSTED EBITDA MARGIN OF 11 PERCENT (11)
* Q4 NET PROFIT AMOUNTED TO SEK 12.2 MILLION (-19.6).
EARNINGS PER
SHARE AMOUNTED TO SEK 0.42 (-0.68)
* Q4 EBIT SEK LOSS 8.3 MILLION VERSUS LOSS SEK 14.3 MILLION
YEAR
AGO
Source text for Eikon: ID:nMFN1HQt5p
Further company coverage: XVIVO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))